Cleerly · 1 week ago
Principal ML Scientist
Cleerly is a healthcare company revolutionizing heart disease diagnosis and treatment. They are seeking a Principal Machine Learning Scientist to lead the development and deployment of advanced machine learning models that impact diagnostic and prognostic care pathways for heart disease, while providing technical leadership and guiding high-stakes projects.
AppsArtificial Intelligence (AI)Health CareMedicalWellness
Responsibilities
Lead the design and development of state-of-the-art ML and deep learning models for complex, multi-modal medical imaging and clinical data across multiple projects
Define technical and research strategies to achieve new business opportunities, and lead proposals to pursue new areas of science or technology in programs to meet the organization’s long-term strategic goals
Set the technical direction for core ML initiatives, balancing scientific rigor with clinical and business priorities. Evangelizes new technology within the company
Drive innovation in data representation, model architecture, and learning paradigms to advance the field and improve clinical outcomes. Establish frameworks and processes that are used across teams
Oversee and guide rigorous validation, benchmarking, and regulatory-aligned evaluation of ML algorithms
Partner with scientific affairs, engineering, product, biostatistician, and regulatory teams to drive the end-to-end lifecycle of medical products to ensure successful delivery and impact. Rally others around a clear vision
Provide support and guidance in all phases of the product development cycle to ensure delivery of high-quality products. Provide design and system optimization solutions to drive improved customer experience and satisfaction
Mentor and guide other ML scientists and engineers, fostering a culture of technical excellence and continuous learning
Lead collaborative research efforts with academic and medical partners; author high-impact publications and contribute to the company’s intellectual property portfolio
Present findings, strategic insights, and technical recommendations to executive leadership and external stakeholders
Qualification
Required
Ph.D. in Computer Science, Biomedical Engineering, Data Science, or a related technical field
8+ years of post Ph.D. or industry experience leading applied ML initiatives
Demonstrated technical leadership in developing and deploying ML models in regulated or clinical domains. Recognized expert in machine learning and medical imaging
Deep expertise in machine learning theory and practice, with a strong track record in 3D medical image analysis, including segmentation, reconstruction, registration, restoration, detection, and/or predictive analytics
Strong track record of publications in top-tier machine learning, medical imaging or computer vision
Preferred
12+ years of post Ph.D. or industry experience leading applied ML initiatives
Hands-on expertise in advanced ML techniques such as vision transformers, self-supervised learning, continual/incremental learning, contrastive learning or physics-informed deep learning
Experience with ML orchestration frameworks, such as Kubeflow, MLFlow, Ray, Metaflow, or Argo Workflow
Strong domain knowledge in cardiac CT and coronary artery disease diagnostics
Experience contributing to 510(k) submissions or working in a regulated SaMD development environment
Company
Cleerly
Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.
H1B Sponsorship
Cleerly has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Growth StageTotal Funding
$386.48MKey Investors
Insight PartnersVensana Capital
2024-12-03Series C· $106M
2022-07-25Series C· $223M
2021-06-21Series B· $43M
Leadership Team
Recent News
2026-01-07
2025-11-27
Company data provided by crunchbase